Amicus Therapeutics Highlights Data Featured at Lysosomal Disease Network WORLD Symposium 2014
[GlobeNewswire] – First Scientific Meeting to Present Preclinical Proof-of-Concept Data for Next-Generation Pompe ERT and Proprietary Enzyme Targeting Technology more
View todays social media effects on FOLD
View the latest stocks trending across Twitter. Click to view dashboard